Thioether Metabolites of 3,4-Methylenedioxyamphetamine and 3,4-Methylenedioxymethamphetamine Inhibit Human Serotonin Transporter (hSERT) Function and Simultaneously Stimulate Dopamine Uptake into hSERT-Expressing SK-N-MC Cells
Authors:
- Serrine S. LauSLSerrine S. Lau
- Terrence J. MonksTMTerrence J. Monks
- 1 October 2004
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 311 (1) , 298-306
Abstract
3,4-Methylenedioxyamphetamine (MDA) and 3,4-methyl-enedioxymethamphetamine (MDMA, ecstasy) are widely abused amphetamine derivatives that target the serotonin system. The serotonergic neurotoxicity of MDA and MDMA seems dependent on their systemic metabolism. 5-(Glutathion-S-yl)-α-methyldopamine [5-(GSyl)-α-MeDA] and 2,5-bis(glutathion-S-yl)-α-methyldopamine [2,5-bis(GSyl)-α-MeDA], metabolites of MDA and MDMA, are also selective serotonergic neurotoxicants and produce behavioral and neurochemical changes similar to those seen with MDA and MDMA. We now show that 5-(GSyl)-α-MeDA and 2,5-bis(GSyl)-α-MeDA are more potent than MDA and MDMA (Ki = 69, 50, 107, and 102 μM, respectively) at inhibiting 5-hy-droxytryptamine (serotonin) transport into SK-N-MC cells transiently transfected with the human serotonin transporter (hSERT). Moreover, 5-(GSyl)-α-MeDA and 2,5-bis(GSyl)-α-MeDA simultaneously stimulated dopamine (DA) transport into the hSERT-expressing cells, an effect attenuated by fluoxetine, indicating that stimulated DA transport was hSERT-dependent. Finally, 5-(GSyl)-α-MeDA and 2,5-bis(GSyl)-α-MeDA, and to a lesser extent MDA and MDMA, induced a concentration and time-dependent increase in reactive oxygen species (ROS) in both hSERT and human dopamine transporter-transfected cells. Fluoxetine attenuated the increase in ROS generation in hSERT-expressing cells. The results are consistent with the view that the serotonergic neurotoxicity of MDA and MDMA may be mediated by the metabolism-dependent stimulation of DA transport into hSERT-expressing cells and ROS generation by redox active catechol-thioether metabolites and DA.Keywords
This publication has 45 references indexed in Scilit:
- The mechanisms involved in the long‐lasting neuroprotective effect of fluoxetine against MDMA (‘ecstasy’)‐induced degeneration of 5‐HT nerve endings in rat brainBritish Journal of Pharmacology, 2001
- Serotonergic Neurotoxicity of 3,4-(±)-Methylenedioxyamphetamine and 3,4-(±)-Methylendioxymethamphetamine (Ecstasy) Is Potentiated by Inhibition of γ-Glutamyl TranspeptidaseChemical Research in Toxicology, 2001
- MDMA induced dopamine release in vivo: role of endogenous serotoninJournal of Neural Transmission, 1997
- Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotoninJournal of Neural Transmission, 1996
- Effects of Intracerebroventricular Administration of 5-(Glutathion-S-yl)-α-methyldopamine on Brain Dopamine, Serotonin, and Norepinephrine Concentrations in Male Sprague-Dawley RatsChemical Research in Toxicology, 1996
- Carrier‐Mediated Release of Serotonin by 3,4‐Methylenedioxymethamphetamine: Implications for Serotonin‐Dopamine InteractionsJournal of Neurochemistry, 1996
- Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): Evidence from using CuZn‐superoxide dismutase transgenic miceSynapse, 1995
- Metabolism of 5-(Glutathion-S-yl)-.alpha.-methyldopamine following Intracerebroventricular Administration to Male Sprague-Dawley RatsChemical Research in Toxicology, 1995
- Synthesis and neurotoxicological evaluation of putative metabolites of the serotonergic neurotoxin 2-(methylamino)-1-[3,4-(methylenedioxy)phenyl]propane [(methylenedioxy)methamphetamine]Chemical Research in Toxicology, 1992
- Transformation of dopamine and .alpha.-methyldopamine by NG108-15 cells: formation of thiol adductsChemical Research in Toxicology, 1991